The topics of promoting patient diversity in the clinical trial population and workforce diversity in the profession continue to receive increased and welcome focus from the drug and device research […]
While the clinical trial industry has performed incredibly well in terms of developing potential vaccines against COVID-19, the next big challenge is to allay concerns many have about taking any […]
The U.S. Food and Drug Administration (FDA) “encourages diverse patients to participate in medical device clinical trials,” the agency says in part of a new series of videos released to […]
“We recognize that achieving clinical trials that include diverse populations presents an ongoing challenge,” the PhRMA trade association says in a recent addition to its white paper on Principles on […]
The U.S. Food and Drug Administration (FDA) drug and biological product centers intend, to the extent appropriate and permitted by law, to publicly post their reviews of the scientific data […]